CoChat

Disease burden and economic impact of diagnosed non‐alcoholic steatohepatitis in five European countries in 2018: A cost‐of‐illness analysis

Open access
Schattenberg, Jörn M., Lazarus, Jeffrey V., Newsome, Philip N., Serfaty, Lawrence, Aghemo, Alessio, Augustin, Salvador, Tsochatzis, Emmanuel, de Ledinghen, Victor, Bugianesi, Elisabetta, Romero‐Gomez, Manuel, Bantel, Heike, Ryder, Stephen D., Boursier, Jerome, Leroy, Vincent, Crespo, Javier, Castera, Laurent, Floros, Lefteris, Atella, Vincenzo, Mestre‐Ferrandiz, Jorge, Elliott, Rachel, Kautz, Achim, Morgan, Alice, Sansom, Sally L., Vasudevan, Sharad, Pezzullo, Lynne, Trylesinski, Aldo, Cure, Sandrine, Higgins, Victoria, Ratziu, Vlad · 2021 · Liver International
Cited by 142

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Background and aims: Non‐alcoholic steatohepatitis (NASH) is a chronic disease that can progress to end‐stage liver disease (ESLD). A large proportion of early‐stage NASH patients remain undiagnosed compared to those with advanced fibrosis, who are more likely to receive disease management interventions. This study estimated the disease burden and economic impact of diagnosed NASH in the adult population of France, Germany, Italy, Spain and the United Kingdom in 2018. Methods: The socioeconomic burden of diagnosed NASH was estimated using cost‐of‐illness methodology applying a prevalence approach to estimate the number of adults with NASH and the attributable economic and wellbeing costs. Given undiagnosed patients do not incur costs in the study, the probability of diagnosis is central to cost estimation. The analysis was based on a literature review, databases and consultation with clinical experts, economists and patient groups. Results: The proportion of adult NASH patients with a diagnosis ranged from 11.9% to 12.7% across countries, which increased to 38.8%‐39.1% for advanced fibrosis (F3‐F4 compensated cirrhosis). Total economic costs were €8548‐19 546M. Of these, health system costs were €619‐1292M. Total wellbeing costs were €41 536‐90 379M. The majority of the undiagnosed population (87.3%‐88.2% of total prevalence) was found to have early‐stage NASH, which, left untreated, may progress to more resource consuming ESLD over time. Conclusions: This study found that the majority of economic and wellbeing costs of NASH are experienced in late disease stages. Earlier diagnosis and care of NASH patients could reduce future healthcare costs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/liv.14825

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 142

Metadata

Authors
Schattenberg, J. M., Lazarus, J. V., Newsome, P. N., Serfaty, L., Aghemo, A., Augustin, S., Tsochatzis, E., de Ledinghen, V., Bugianesi, E., Romero‐Gomez, M., Bantel, H., Ryder, S. D., Boursier, J., Leroy, V., Crespo, J., Castera, L., Floros, L., Atella, V., Mestre‐Ferrandiz, J., Elliott, R., Kautz, A., Morgan, A., Sansom, S. L., Vasudevan, S., Pezzullo, L., Trylesinski, A., Cure, S., Higgins, V., & Ratziu, V.
Venue
Liver International
Publisher
Wiley
Published
2021-03-18
Volume
41
Issue
6
Pages
1227-1242
ISSN
  • 0106-9543 (ISSN-L)
  • 1478-3223
  • 1478-3231
OpenAlex
W3133101076
Cited by
142
References
3
FWCI
15.93
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Disease burden and economic impact of diagnosed non‐alcoholic steatohepatitis in five European countries in 2018: A cost‐of‐illness analysis. https://app.cochat.ai/papers/10.1111/liv.14825
The paper
Schattenberg, J. M., Lazarus, J. V., Newsome, P. N., Serfaty, L., Aghemo, A., Augustin, S., Tsochatzis, E., de Ledinghen, V., Bugianesi, E., Romero‐Gomez, M., Bantel, H., Ryder, S. D., Boursier, J., Leroy, V., Crespo, J., Castera, L., Floros, L., Atella, V., Mestre‐Ferrandiz, J., . . . Ratziu, V. (2021). Disease burden and economic impact of diagnosed non‐alcoholic steatohepatitis in five European countries in 2018: A cost‐of‐illness analysis. Liver International. https://doi.org/10.1111/liv.14825

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.